Primary immunodeficiency disorders: Antibody deficiency

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 4, 2002, Pages 581-591

  Ballow, Mark ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antibody deficiencies; B cell development and differentiation; Primary immune deficiencies

Indexed keywords

ANTIBIOTIC AGENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLAMINE; PHENYTOIN; PNEUMOCOCCUS VACCINE; RECOMBINANT INTERLEUKIN 2; SALAZOSULFAPYRIDINE;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW TRANSPLANTATION; CELL MATURATION; CELLULAR IMMUNITY; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GASTROINTESTINAL DISEASE; GENE MUTATION; GENE THERAPY; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERIMMUNOGLOBULINEMIA M; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G DEFICIENCY; INFECTION; INHERITANCE; MALIGNANT NEOPLASTIC DISEASE; PALLIATIVE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SIDE EFFECT; T LYMPHOCYTE; TREATMENT OUTCOME; X LINKED AGAMMAGLOBULINEMIA;

EID: 0036224043     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.122466     Document Type: Article

References (115)

1. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
2. B-cell development and differentiation
3. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
4. New views of BCR structure and organization
5. Signal transduction elements of the B cell antigen receptor and their role in immunodeficiencies
6. Requirement for B cell linker protein (BLNK) in B cell development
7. Agammaglobulinemia
8. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
9. Linkage analysis and physical mapping near the gene for X-linked agammaglobulinemia
10. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation
11. Expression of the gene defect in X-linked agammaglobulinemia
12. Molecular and cellular aspects of X-linked agammaglobulinemia
13. B cells in patients with X-linked agammaglobulinemia
14. X-linked agammaglobulinemia: An analysis of 96 patients
15. Fatal complications of virus hepatitis in two patients with agammaglobulinemia
16. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia
17. Persistent and fatal central nervous-system ECHO virus infections in patients with agammaglobulinemia
18. Collagen disease in patients with congenital agammaglobulinemia
19. Dermatomyositis with cerebral vasculitis in a patient with agammaglobulinemia
20. Chronic group A coxsackievirus infection in agammaglobulinemia: Demonstration of genomic variation of serotypically identical isolates persistently excreted by the same patient
21. Urea-plasma urealyticum chronic osteomyelitis in a patient with hypogammaglobulinemia
22. Tumors in patients with common variable immunodeficiency
23. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients
24. Circulating B-cells in patients with immunodeficiency
25. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia
26. BTKbase, mutation database for X-linked agammaglobulinemia (XLA)
27. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia
28. Autosomal recessive agammaglobulinemia
29. Mutations in Ig (CD79a) result in a complete block in B-cell development
30. Mutations in the human h5/14.1 gene result in B cell deficiency and agammaglobulinemia
31. An essential role for BLNK in human B cell development
32. Mutations in the mu heavy chain gene in patients with agammaglobulinemia
33. Immunodeficiency with hyper-IgM (HIM)
34. Mutations in activation induced cytidine deaminase in patients with hyper IgM syndrome
35. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2)
36. Immunodeficiency with hyper immunoglobulinemia M in two female patients is not associated with abnormalities of CD40 or CD40 ligand expression
37. The clinical spectrum of X-linked hyper IgM syndrome
38. Identification of a CD40L gene mutation and genetic counseling in a family with immunodeficiency with hyperglobulinemia M
39. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM
40. A disease gene for autosomal hyper-IgM syndrome: More genes associated with more immunodeficiencies
41. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia
42. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)
43. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency
44. Common variable immunodeficiency: Clinical and immunological features of 248 patients
45. Idiopathic late-onset immunoglobulin deficiency: Clinical observations in 50 patients
46. Septic osteomyelitis and polyarthritis with ureaplasma in hypogammaglobulinemia
47. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia
48. Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes. A study of 39 patients
49. Dysgammaglobulinemia associated with nodular lymphoid hyperplasia of the small intestine
50. Childhood common variable immunodeficiency with autoimmune disease
51. Incidence of cancer in 98 patients with common variable immunodeficiency
52. Granulomatous disease in common variable immunodeficiency
53. Primary immunodeficiencies: Report of a World Health Organization committee
54. Heterogeneity of "acquired" or common variable agammaglobulinemia
55. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia
56. Immunodeficiency associated with loss of T4+ inducer T-cell function
57. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency
58. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-BD40 antibody and IL-10
59. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency
60. Individuals with IgA deficiency and common variable immunodeficiency share complex polymorphisms of major histocompatibility complex class III genes
61. Major histocompatibility complex class III genes and susceptibility to IgA deficiency and common variable immunodeficiency
62. Genetics of IgA deficiency and common variable immunodeficiency
63. Genetic and immunologic analysis of a family containing five patients with common variable immune deficiency or selective IgA deficiency
64. Studies on the serum g-A-globulin level. III. The frequency of a g-A-globulinemia
65. Ataxia-telangiectasia: Its association with defective thymus, immunological deficiency disease and malignancy
66. IgG subclasses in selective IgA deficiency
67. IgA deficiency, epilepsy, and phenytoin treatment
68. D-penicillamine-induced IgA deficiency in Wilson's disease
69. Absent IgA and deletions of chromosome 18
70. Familial selective IgA deficiency
71. Selective immunoglobulin A deficiency and intestinal nodular lymphoid hyperplasia: Correction of diarrhea with antibiotics and plasma
72. Selective IgA deficiency: Presentation of 30 cases and a review of the literature
73. Physiology of IgA and IgA deficiency
74. Celiac sprue and immunodeficiency states: A 25-year review
75. IgA deficiency
76. IgA deficiency
77. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)
78. Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3
79. Anaphylactoid transfusion reactions associated with anti-IgA
80. Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies
81. Immature IgA B cells in IgA deficient patients
82. Transient hypogammaglobulinemia of infancy: Review of the literature, clinical and immunologic features of 11 new cases, and long-term follow-up
83. Transient hypogammaglobulinemia of infancy: Need to reconsider name and definition
84. Absent specific viral antibodies in patients with transient hypogammaglobulinemia of infancy
85. Imbalances of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemia
86. Selective gamma-G globulin deficiencies in patients with recurrent pyogenic infections
87. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2
88. Immunoglobulin subclasses in normal children
89. Correlations between the concentrations of the four subclasses of IgG and Gm allotypes in normal human serum
90. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria
91. Immunoglobulin G subclass deficiencies
92. Quantitative and qualitative investigations of serum IgG subclasses in immunodeficiency diseases
93. Relationship between IgA and IgG subclass deficiencies: A reappraisal
94. Multiple gene deletions within the human immunoglobulin heavy-chain cluster
95. Immunologic compensation in a patient with a large IgH constant region deletion
96. Serum IgG subclasses in chronic and recurrent respiratory infections
97. IgG subclass distribution of antibody induced by immunization with the isolated and protein conjugated polysaccharide of H. influenzae b and G2m(n) distribution of serum IgG2 in man
98. An immunodeficiency characterized by impaired antibody responses to polysaccharides
99. Selective defect in the antibody response to H influenzae type b in children with recurrent infectious and normal serum IgG subclass levels
100. Haemophilus influenzae type b disease in children previously vaccinated with type b polysaccharide vaccine
101. Selective antibody deficiency to Hemophilus influenzae type b capsular polysaccharide vaccination in children with recurrent respiratory tract infection
102. Benefits of antibiotic prophylaxis in children with chronic sinusitis: Assessment of outcome predictors
103. Immunologic defects in patients with refractory sinusitis
104. Serum levels of immune globulins in health and disease. A survey
105. IgG subclass deficiency: A personal viewpoint
106. Immunodeficiency disorders: General considerations
107. IgG subclass distribution of antibodies to bacterial and viral antigens
108. Replacement intravenous immune serum globulin therapy in patients with antibody immune deficiency
109. Therapeutic applications of intravenous immune serum globulin
110. The use of intravenous immune globulin in immunodeficiency diseases
111. Intravenous immunoglobulin treatment in the primary immunodeficiency diseases
112. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinemia and chronic lung disease
113. Anaphylactic reactions after gamma globulin-administration in patients with hypogammaglobulinemia: Detection of IGE antibodies to IgA
114. Long-term low-dose TL-2 enhances immune function in common variable immunodeficiency
115. The potential for therapy of immune disorders with gene therapy